Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (6): 529-534.DOI: 10.3969/j.issn.1673-8640.2022.06.006

Previous Articles     Next Articles

Relationship between ADAMTS-13 activity and non-ST-segment elevation myocardial infarction

WANG Bin   

  1. Department of Clinical Laboratory,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,Hubei,China
  • Received:2021-01-11 Revised:2021-08-19 Online:2022-06-30 Published:2022-07-28

Abstract:

Objective To investigate the clinical role of a disintegrin and metalloproteinase with thrombospondin motif 13(ADAMTS-13)in identifying high-risk non-ST-segment elevation myocardial infarction(NSTEMI). Methods ADAMTS-13 activity determination was performed on the samples collected from 142 patients with NSTEMI(NSTEMI group) through a fluorescence resonance energy transfer(FRET)-based assay. Totally,50 non-coronary heart disease patients with normal coronary angiography were enrolled as control group during the same period. The baseline information,clinical data and determination results [creatinine(Cr),high-sensitivity cardiac troponin I(hs-cTnI),platelet(PLT) count,D-dimer(DD)] were collected. According to the Global Registry of Acute Coronary Events(GRACE)score at admission,the NSTEMI patients were classified into low-risk group(43 cases),medium-risk group(54 cases)and high-risk group(45 cases). Spearman rank correlation analysis was used to analyze the correlation between ADAMTS-13 activity and risk stratification in NSTEMI patients. Binary Logistic regression analysis was used to investigate the influencing factors for high-risk NSTEMI. Receiver operating characteristic(ROC)curve was used to evaluate the clinical value of ADAMTS-13 on high-risk NSTEMI. Results The ADAMTS-13 activity in NSTEMI group was lower than that in control group(P<0.001),and it was decreased from low-risk,medium-risk to high-risk groups(P<0.01). Spearman rank correlation analysis results showed that,ADAMTS-13 activity was negatively correlated with risk stratification in NSTEMI patients(rs=-0.527,P<0.001 ). Binary Logistic regression analysis showed that ADAMTS-13 was a protective factor [odds ratio(OR)=0.936,95% confidence interval(CI) 0.898-0.975]. Age,heart rate,Cr and Killip grading ≥Ⅱ were risk factors(OR=1.148,1.085,1.023 and 26.207,95%CI 1.047-1.259,1.023-1.150,1.004-1.041 and 5.489-125.136). ROC curve analysis indicated that the area under curve(AUC) of ADAMTS-13 activity in predicting high-risk NSTEMI was 0.784. When the optimal cut-off value was 61.7%,the sensitivity and specificity were 71.1% and 81.4%,respectively. Conclusions ADAMTS-13 activity is related to the risk stratification of NSTEMI,which has clinical value in the diagnosis of high-risk NSTEMI.

Key words: A disintegrin and metalloproteinase with thrombospondin motif 13, Non-ST-segment elevation myocardial infarction, High-risk, Global Registry of Acute Coronary Events

CLC Number: